Cargando…
EGFR, FLT1 and Heparanase as Markers Identifying Patients at Risk of Short Survival in Cholangiocarcinoma
BACKGROUND: Cholangiocarcinoma remains to be a tumor with very few treatment choices and limited prognosis. In this study, we sought to determine the prognostic role of fms-related tyrosine kinase 1/vascular endothelial growth factor receptor 1 (FLT1/VEGFR1), heparanase (HPSE) and epidermal growth f...
Autores principales: | Hoffmann, Andreas-Claudius, Goekkurt, Eray, Danenberg, Peter V., Lehmann, Sylvia, Ehninger, Gerhard, Aust, Daniela E., Stoehlmacher-Williams, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660514/ https://www.ncbi.nlm.nih.gov/pubmed/23704979 http://dx.doi.org/10.1371/journal.pone.0064186 |
Ejemplares similares
-
Reply: Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastasis from colorectal cancer
por: Goekkurt, E, et al.
Publicado: (2006) -
Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer
por: Folprecht, Gunnar, et al.
Publicado: (2014) -
Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients
por: Goekkurt, E, et al.
Publicado: (2006) -
Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling
por: Song, Jin-Wen, et al.
Publicado: (2017) -
Heparanase and Autoimmune Diabetes
por: Simeonovic, Charmaine J., et al.
Publicado: (2013)